The binding of OTULIN restrains LUBAC activity to prevent TNF-driven immunopathology

This study reveals that the direct physical interaction between OTULIN and LUBAC serves as a critical regulatory brake that restrains LUBAC's enzymatic activity and Met1-Ub accumulation to prevent TNF-driven immunopathology and maintain tissue integrity during acute immune responses.

The Gist

The Story of the Overzealous Firefighter

Imagine your body is a bustling city. When a threat appears (like a virus or bacteria), the city's emergency services need to spring into action. One of the most important emergency signals is a siren called TNF (Tumor Necrosis Factor). When TNF sounds the siren, it tells the immune cells: "Wake up! Fight the infection! Make more alarms!"

To make sure this alarm system works, the city uses a special construction crew called LUBAC. LUBAC's job is to build "Met1-Ub" chains. Think of these chains as construction scaffolding. They hold the emergency equipment together so the signal gets loud and clear, and they also act as a shield to protect the cells from accidentally destroying themselves while fighting.

However, if you build too much scaffolding, the construction site becomes a chaotic mess. The signal gets too loud, the immune system goes into overdrive, and the city starts burning itself down. This is called inflammation or an "immune storm."

To prevent this disaster, the city has a Demolition Crew called OTULIN. OTULIN's job is to cut down the scaffolding (the Met1-Ub chains) once the job is done, keeping the signal at a safe, manageable level.

The Big Discovery: A New Kind of Brake

For a long time, scientists thought OTULIN's only job was to be the "Demolition Crew"—cutting the chains to stop the signal. If you lost OTULIN completely, the scaffolding would pile up, the signal would scream, and the body would die from inflammation.

But this paper discovered something surprising. OTULIN has a second job: it acts as a physical brake on the construction crew (LUBAC) itself.

The researchers created a special type of mouse where OTULIN could still cut chains (it was still a good demolition crew), but it couldn't hold hands with the construction crew (LUBAC). They broke the physical connection between the two.

Here is what happened:

1. The "Brake" is Broken: Even though OTULIN was still there to cut chains, because it couldn't hold onto LUBAC, the construction crew went wild. They started building scaffolding on themselves (auto-ubiquitination) and then used that extra energy to build even more scaffolding on the emergency signals.
2. The Signal Gets Too Loud: In these mice, when the TNF alarm sounded, the scaffolding piled up way too high. The immune signal became super-charged.
3. The Result:
   • In a quiet city (no infection): The mice were fine. They didn't get sick spontaneously. The "Demolition Crew" was still cutting chains, so things were mostly okay.
   • In a crisis (infection or injected TNF): The mice reacted too strongly. Their bodies went into a massive inflammatory shock. They got very sick, their bodies got cold (hypothermia), and their organs started to fail.

The Twist: It's Not About Cell Death

Usually, when inflammation gets too high, cells die (apoptosis) to stop the fight. The researchers expected that breaking the connection between OTULIN and LUBAC would make cells more likely to die.

Surprise! It did the opposite.
Because the scaffolding (Met1-Ub) was so high, the cells were actually protected from dying. They were so well-shielded by the extra scaffolding that they kept fighting even when they should have stopped. This led to a "cytokine storm"—a massive release of inflammatory chemicals that damaged the body's tissues without actually killing the cells to stop the process.

The Real-World Test: The Listeria Infection

To see if this mattered in real life, the scientists infected these mice with Listeria bacteria.

• The Good News: The mice were just as good at killing the bacteria as normal mice. The immune system worked perfectly to clear the infection.
• The Bad News: Because the immune response was so over-the-top (due to the broken "brake"), the mice suffered from severe tissue damage. They lost weight, their blood counts crashed, and they felt terrible, even though the bacteria were gone.

It's like a firefighter who is so good at putting out a fire that they end up flooding the entire house with water. The fire is out, but the house is ruined.

The Conclusion

This paper teaches us that OTULIN isn't just a pair of scissors cutting chains; it's also a handshake that calms down the construction crew.

• Without OTULIN entirely: The body has no brakes and no demolition crew. It dies from inflammation during development.
• Without the OTULIN-LUBAC handshake: The body has a demolition crew, but the construction crew is running wild. The body survives normally until it faces a real threat, at which point it overreacts so violently that it damages its own tissues.

In short: The physical connection between OTULIN and LUBAC acts as a critical "dimmer switch" for our immune system. It ensures that when we fight an infection, we fight hard enough to win, but not so hard that we destroy ourselves in the process.

Technical Summary

1. Problem Statement

The linear ubiquitin chain assembly complex (LUBAC) and the deubiquitinase OTULIN are critical regulators of Met1-linked ubiquitin (Met1-Ub) chains, which govern inflammatory signaling via the TNF receptor (TNFR1).

• Known Context: OTULIN's catalytic activity is essential to prevent autoinflammatory diseases (ORAS) and embryonic lethality by removing Met1-Ub. It is known that OTULIN interacts with LUBAC via a PUB-interacting motif (PIM) binding to the HOIP PUB domain.
• The Gap: While OTULIN's enzymatic function is well-characterized, the physiological significance of its physical interaction with LUBAC (independent of its catalytic activity) remains unclear. It was previously hypothesized that LUBAC auto-ubiquitination inhibits LUBAC function, but the specific regulatory role of the OTULIN-LUBAC binding interface in vivo was unknown.

2. Methodology

The authors employed a multidisciplinary approach combining genetics, biochemistry, cell biology, and in vivo infection models:

• Genetic Mouse Model: Generation of knock-in mice carrying a point mutation in the OTULIN PIM (Tyrosine 56 to Alanine; OTULIN$^{Y56A}$). This mutation disrupts the physical binding to LUBAC (HOIP) while preserving OTULIN's catalytic deubiquitinating activity.
• Cellular Models: Use of primary cells (fibroblasts, macrophages) from WT and $Otulin^{Y56A/Y56A}$ mice, alongside reconstituted OTULIN-deficient cell lines (NIH 3T3, MEFs) expressing WT, catalytically inactive ($C129A$), or binding-deficient ($Y56A$) OTULIN variants.
• Biochemical Assays:
  • Immunoprecipitation (IP) and proximity labeling (TurboID) to assess protein interactions.
  • In vitro ubiquitination assays using purified LUBAC to measure Met1-Ub assembly rates.
  • Sequential pulldown of TNF-bound TNF-RSC followed by Met1-Ub enrichment to track complex dynamics.
  • Mass spectrometry for proteomic profiling of signaling complexes.
• In Vivo Challenges:
  • Acute TNF injection (mouse and human TNF) to assess systemic inflammatory response syndrome (SIRS) and lethality.
  • Listeria monocytogenes infection to evaluate disease tolerance and pathogen control.
• Pharmacological Interventions: Use of RIPK1 inhibitors (Necrostatin-1s), TAK1 inhibitors, and TNF-neutralizing antibodies to dissect cell death pathways.

3. Key Contributions

The study fundamentally redefines the regulatory mechanism of LUBAC by distinguishing between OTULIN's catalytic role and its structural role as a "brake" on LUBAC activity.

• Discovery of a Non-Redundant Regulatory Axis: The physical interaction between OTULIN and LUBAC is distinct from OTULIN's enzymatic activity. While catalytic activity is required for embryonic survival, the binding interaction is dispensable for development but critical for preventing hyper-inflammatory responses.
• Mechanism of LUBAC Activation: The paper challenges the prevailing view that LUBAC auto-ubiquitination is purely inhibitory. Instead, it demonstrates that the OTULIN-LUBAC interaction restrains LUBAC activity. Disruption of this binding leads to enhanced Met1-Ub assembly on substrates, not inhibition.
• Stabilization of Signaling Complexes: The authors show that the OTULIN-LUBAC interaction prevents the stabilization of the TNF-RSC after TNF dissociation, thereby limiting the duration and intensity of NF-κB signaling.

4. Key Results

A. Physiological Phenotype of $Otulin^{Y56A/Y56A}$ Mice

• Viability: Unlike OTULIN-deficient mice (which die embryonically) or catalytically inactive mice (which develop spontaneous autoinflammation), $Otulin^{Y56A/Y56A}$ mice are viable, fertile, and show no spontaneous inflammation.
• TNF Hypersensitivity: Upon systemic TNF challenge, $Otulin^{Y56A/Y56A}$ mice exhibit rapid hypothermia, cytokine storm (elevated IL-6, TNF, CXCL1), and lethality. This pathology is driven by TNFR1 signaling.
• Cell Death Mechanism: The lethality is not primarily driven by RIPK1 kinase-mediated necroptosis (as Nec1s only delayed, but did not prevent, death). Instead, the mice show early crypt-specific intestinal apoptosis and delayed hepatocyte apoptosis, suggesting a shift toward NF-κB-driven inflammatory pathology rather than cell death sensitization.

B. Molecular Mechanisms

• Enhanced Met1-Ub Accumulation: In $Otulin^{Y56A/Y56A}$ cells, there is increased Met1-linked auto-ubiquitination of LUBAC subunits (HOIL-1 and HOIP). Crucially, this auto-ubiquitination enhances rather than inhibits LUBAC's ability to conjugate Met1-Ub to substrates.
• In Vitro Activity: Purified auto-ubiquitinated LUBAC from $Y56A$ cells assembled Met1-Ub chains more efficiently than de-ubiquitinated LUBAC.
• TNF-RSC Dynamics: Disruption of the OTULIN-LUBAC interaction leads to:
  1. Increased accumulation of Met1-Ub at the TNF-RSC.
  2. Enhanced recruitment of NF-κB signaling components (NEMO, IKK$\beta$, A20, ABINs).
  3. Stabilization of the complex: The TNF-RSC remains assembled and active even after TNF dissociation, leading to prolonged NF-κB signaling and excessive cytokine production.
• Protection from Apoptosis: Contrary to OTULIN loss (which sensitizes to apoptosis), the $Y56A$ mutation protects cells from TNF-induced apoptosis, likely due to the hyper-activation of survival pathways (NF-κB).

C. Infection Model (Listeria monocytogenes)

• Disease Tolerance: During Listeria infection, $Otulin^{Y56A/Y56A}$ mice suffer from severe weight loss and immunopathology despite having comparable bacterial loads to WT mice.
• TNF Dependence: Neutralizing TNF improved the fitness of $Y56A$ mice, confirming that the pathology is driven by an exaggerated TNF response (cytokine storm) rather than a failure to clear the pathogen.

5. Significance

• Therapeutic Implications: The findings suggest that inflammatory diseases driven by LUBAC hyperactivity might be treatable by targeting the protein-protein interaction between OTULIN and LUBAC, rather than just inhibiting enzymatic activity. This offers a new avenue for treating autoinflammatory disorders without completely abolishing Met1-Ub signaling, which is essential for host defense.
• Conceptual Shift: The study overturns the dogma that LUBAC auto-ubiquitination is an inhibitory "off-switch." Instead, it proposes a model where OTULIN acts as a "brake" that prevents LUBAC from extending Met1-Ub chains on itself, thereby keeping LUBAC in a state ready to modify other substrates. When the brake is released (via Y56A mutation), LUBAC becomes hyperactive, leading to pathological inflammation.
• Disease Tolerance: The work highlights a critical mechanism of "disease tolerance," where the host limits immune-mediated tissue damage during infection without compromising pathogen clearance, mediated specifically by the OTULIN-LUBAC physical interaction.